Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Aurobindo Pharma Ltd fell 3.92% today to trade at Rs 1194. The BSE Healthcare index is down 1.06% to quote at 41928.48. The index is up 3.45 % over last one month. Among the other constituents of the index, Lupin Ltd decreased 3.13% and Cipla Ltd lost 2.64% on the day. The BSE Healthcare index went up 17.28 % over last one year compared to the 9.41% surge in benchmark SENSEX.
Aurobindo Pharma Ltd has added 8.07% over last one month compared to 3.45% gain in BSE Healthcare index and 7.28% rise in the SENSEX. On the BSE, 5911 shares were traded in the counter so far compared with average daily volumes of 53449 shares in the past one month. The stock hit a record high of Rs 1592.55 on 13 Sep 2024. The stock hit a 52-week low of Rs 994.35 on 07 Apr 2025.
DCM Shriram Ltd, Cipla Ltd, Cummins India Ltd, Kama Holdings Ltd are among the other stocks to see a surge in volumes on BSE today, 06 May 2025.
CCL Products (India) Ltd registered volume of 3.73 lakh shares by 10:47 IST on BSE, a 123.01 fold spurt over two-week average daily volume of 3030 shares. The stock rose 13.60% to Rs.675.10. Volumes stood at 5580 shares in the last session.
DCM Shriram Ltd saw volume of 50366 shares by 10:47 IST on BSE, a 24.14 fold spurt over two-week average daily volume of 2086 shares. The stock increased 5.96% to Rs.1,078.90. Volumes stood at 3522 shares in the last session.
Cipla Ltd witnessed volume of 7.21 lakh shares by 10:47 IST on BSE, a 23.49 times surge over two-week average daily volume of 30717 shares. The stock dropped 1.91% to Rs.1,513.65. Volumes stood at 23016 shares in the last session.
Cummins India Ltd notched up volume of 20204 shares by 10:47 IST on BSE, a 4.03 fold spurt over two-week average daily volume of 5009 shares. The stock slipped 4.26% to Rs.2,815.50. Volumes stood at 3165 shares in the last session.
Kama Holdings Ltd saw volume of 15746 shares by 10:47 IST on BSE, a 3.25 fold spurt over two-week average daily volume of 4851 shares. The stock increased 5.43% to Rs.2,689.50. Volumes stood at 2634 shares in the last session.
In an email communication dated 11 April 2025, which was received by Cipla on 17 April 2025, the USFDA confirmed the VAI classification for the facility.
The official announcement was made on Thursday, 17 April 2025, after market hours.
Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolios in our home markets of India, South Africa, North America, and key regulated and emerging markets.
The pharma major’s consolidated net profit jumped 48.73% to Rs 1,570.51 crore in Q3 FY25 as against Rs 1,055.90 crore reported in Q3 FY24. Total revenue from operations grew by 7.10% year on year (YoY) to Rs 7,072.97 crore in the quarter ended 31 December 2024.
The counter rose 0.34% to Rs 1,520.65 on the BSE.
Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 1,61,52,80,804 comprising of 80,76,40,402 equity shares of face value Rs 2 each.